Microglia amplify inflammatory activation of astrocytes in manganese neurotoxicity

Journal of Neuroinflammation

Volumn 14, Issue 1, 2017, Pages

  Kirkley, Kelly S ^a   Popichak, Katriana A ^a   Afzali, Maryam F ^a   Legare, Marie E ^a   Tjalkens, Ronald B ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Glial crosstalk; Manganism; Neuroinflammation; NF B; Tumor necrosis factor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MANGANESE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SMALL INTERFERING RNA; SOMATOMEDIN C; TUMOR NECROSIS FACTOR; AUTACOID;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL STRUCTURE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOFLUORESCENCE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; PHENOTYPE; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; COCULTURE; DRUG EFFECTS; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; ASTROCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; INFLAMMATION MEDIATORS; MANGANESE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA;

EID: 85018725906     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-017-0871-0     Document Type: Article

References (76)

1. Guilarte TR. Manganese and Parkinson's disease: a critical review and new findings. Environ Health Perspect. 2010;118:1071-80.
2. Neal AP, Guilarte TR. Mechanisms of heavy metal neurotoxicity: lead and manganese. J Drug Metab Toxicol S. 2012;5:2.
3. Huang C-C. Parkinsonism induced by chronic manganese intoxication-an experience in Taiwan. Chang Gung Med J. 2007;30:385-95.
4. Zhao F, Cai T, Liu M, Zheng G, Luo W, Chen J. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism. Toxicological Sciences. 2008;107:156-64.
5. Verina T, Kiihl SF, Schneider JS, Guilarte TR. Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. NeuroToxicology. 2011;32:215-26.
6. Spranger M, Schwab S, Desiderato S, Bonmann E, Krieger D, Fandrey J. Manganese augments nitric oxide synthesis in murine astrocytes: a new pathogenetic mechanism in manganism? Experimental Neurology. 1998;149:277-83.
7. Moreno JA, Sullivan KA, Carbone DL, Hanneman WH, Tjalkens RB. Manganese potentiates nuclear factor-kappaB-dependent expression of nitric oxide synthase 2 in astrocytes by activating soluble guanylate cyclase and extracellular responsive kinase signaling pathways. J Neurosci Res. 2008;86:2028-38.
8. Filipov NM, Seegal RF, Lawrence DA. Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicol Sci Oxford University Press. 2005;84:139-48.
9. Crittenden PL, Filipov NM. Manganese modulation of MAPK pathways: effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells. J Appl Toxicol. 2011;31:1-10. John Wiley & Sons, Ltd.
10. Zhang P, Wong TA, Lokuta KM, Turner DE, Vujisic K, Liu B. Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: role of free radical generation. Experimental Neurology. 2009;217:219-30.
11. Kraft AD, McPherson CA, Harry GJ. Heterogeneity of microglia and TNF signaling as determinants for neuronal death or survival. NeuroToxicology. 2009;30:785-93.
12. Kim SU, de Vellis J. Microglia in health and disease. J Neurosci Res. 2005;81:302-13.
13. Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: intrinsic immuneffector cell of the brain. Brain Research Reviews. 1995;20:19-9.
14. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6(13):1-13.
15. Crain JM, Nikodemova M, Watters JJ. Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. J Neurosci Res. 2013;91:1143-51.
16. Zhang D, Hu X, Qian L, O'Callaghan JP, Hong J-S. Astrogliosis in CNS pathologies: is there a role for microglia? Mol Neurobiol Humana Press Inc. 2010;41:232-41.
17. Frank-Cannon TC, Alto LT, McAlpine FE, Tansey MG. Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegeneration. 2009;4:47.
18. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. Journal of Neuroscience. 2009;29:13435-44.
19. González-Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci. 1999;22:219-40.
20. Minghetti L, Ajmone-Cat MA, De Berardinis MA, De Simone R. Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation. Brain Research Reviews. 2005;48:251-6.
21. Block ML, Hong J-S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Progress in Neurobiology. 2005;76:77-98.
22. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140:918-34.
23. Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol. 2009;8:382-97.
24. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, et al. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell [Internet] Elsevier Ltd. 2009;137:47-59.
25. ASCHNER M, Gannon M, Kimelberg HK. Manganese uptake and efflux in cultured rat astrocytes. J Neurochem. 1992;58:730-5.
26. Streifel KM, Moreno JA, Hanneman WH, Legare ME, Tjalkens RB. Gene deletion of nos2 protects against manganese-induced neurological dysfunction in juvenile mice. Toxicological Sciences. 2012;126:183-92.
27. Magness ST, Jijon H, Van Houten FN, Sharpless NE, Brenner DA, Jobin C. In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse. J Immunol. 2004;173:1561-70.
28. ASCHNER M, Kimelberg HK. The use of astrocytes in culture as model systems for evaluating neurotoxic-induced-injury. NeuroToxicology. 1991;12:505-17.
29. Carbone DL, Popichak KA, Moreno JA, Safe S, Tjalkens RB. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nitric-oxide synthase 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosis. Molecular Pharmacology. 2008;75:35-43.
30. Gordon RR, Hogan CEC, Neal MLM, Anantharam VV, Kanthasamy AGA, Kanthasamy AA. A simple magnetic separation method for high-yield isolation of pure primary microglia. J Neurosci Methods. 2011;194:287-96.
31. Bonilla E, Salazar E, Villasmil JJ, Villalobos R. The regional distribution of manganese in the normal human brain. Neurochem Res. 1982;7:221-7.
32. Moreno JA, Yeomans EC, Streifel KM, Brattin BL, Taylor RJ, Tjalkens RB. Age-dependent susceptibility to manganese-induced neurological dysfunction. Toxicological Sciences. 2009;112:394-404.
33. ATSDR US. Toxicological profile for manganese. 2012.
34. Reaney SH, Bench G, Smith DR. Brain accumulation and toxicity of Mn(II) and Mn(III) exposures. Toxicol Sci Oxford University Press. 2006;93:114-24.
35. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nature Protocols. 2008;3(6):1101-8.
36. Morrison HW, Filosa JA. A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion. J Neuroinflammation. 2013;10:782. PMID: 23311642.
37. Lawson LJL, Perry VHV, Dri PP, Gordon SS. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 1990;39:151-70.
38. Herculano HS. The glia/neuron ratio: how it varies uniformly across brain structures and species and what that means for brain physiology and evolution. Glia. 2014;62:1377-91.
39. De Miranda BR, Popichak KA, Hammond SL, Jorgensen BA, Phillips AT, Safe S, et al. The Nurr1 activator 1,1-bis(3'-indolyl)-1-(p-chlorophenyl)methane blocks inflammatory gene expression in BV-2 microglial cells by inhibiting nuclear factor ΚB. Molecular Pharmacology American Society for Pharmacology and Experimental Therapeutics. 2015;87:1021-34.
40. Yang L, Liu C-C, Zheng H, Kanekiyo T, Atagi Y, Jia L, et al. LRP1 modulates the microglial immune response via regulation of JNK and NF-ΚB signaling pathways. J Neuroinflammation. 2016;13:304. BioMed Central.
41. Kwakye GF, Li D, Kabobel OA, Bowman AB. Cellular fura-2 manganese extraction assay (CFMEA). Curr Protoc Toxicol. Hoboken, NJ, USA: John Wiley & Sons, Inc; 2011; Chapter 12: Unit 12.18-12.18.20.
42. Ransohoff RM, Perry VH. Microglial physiology: unique stimuli. Specialized Responses Annu Rev Immunol. 2009;27:119-45.
43. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AMG. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci Nature Publishing Group. 2007;8:766-75.
44. Hanisch UK. Microglia as a source and target of cytokines. Glia Wiley Subscription Services, Inc, A Wiley Company. 2002;40:140-55.
45. Moreno JA, Streifel KM, Sullivan KA, Legare ME, Tjalkens RB. Developmental exposure to manganese increases adult susceptibility to inflammatory activation of glia and neuronal protein nitration. Toxicol Sci. 2009;112:405-15.
46. Levesque S, Taetzsch T, Lull ME, Kodavanti U, Stadler K, Wagner A, et al. Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity. Environ Health Perspect. 2011;119:1149-55.
47. Lee SC, Liu W, Brosnan CF, Dickson DW. GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia Wiley Subscription Services, Inc, A Wiley Company. 1994;12:309-18.
48. Horvath RJ, Nutile-McMenemy N, Alkaitis MS, DeLeo JA. Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures. J Neurochem. 2008;107:557-69.
49. Stansley B, Post J, Hensley K. A comparative review of cell culture systems for the study of microglial biology in Alzheimer's. J Neuroinflammation. 2012;9:115-123.
50. Norden DM, Trojanowski PJ, Villanueva E, Navarro E, Godbout JP. Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge. Glia. 2016;64:300-16.
51. Walz W, Lang MK. Immunocytochemical evidence for a distinct GFAP-negative subpopulation of astrocytes in the adult rat hippocampus. Neurosci Lett. 1998;257:127-30.
52. Ong WYW, Leong SKS, Garey LJL, Reynolds RR, Liang AWA. An immunocytochemical study of glutamate receptors and glutamine synthetase in the hippocampus of rats injected with kainate. Exp Brain Res. 1996;109:251-67.
53. Kimelberg HK. The problem of astrocyte identity. Neurochemistry International. 2004;45:191-202.
54. Filipov NM, Dodd CA. Role of glial cells in manganese neurotoxicity. J Appl Toxicol. 2011;32:310-7.
55. Zhang P, Lokuta KM, Turner DE, Liu B. Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia. J Neurochem [Internet]. 2010;112:434-43.
56. Zhang P, Hatter A, Liu B. Manganese chloride stimulates rat microglia to release hydrogen peroxide. Toxicology Letters. 2007;173:88-100.
57. Erikson KMK, Aschner MM. Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter. NeuroToxicology. 2006;27:6-6.
58. Skjørringe T, Burkhart A, Johnsen KB, Moos T. Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology. Front Mol Neurosci Frontiers. 2015;8:19.
59. He M, Dong H, Huang Y, Lu S, Zhang S, Qian Y, et al. Astrocyte-derived CCL2 is associated with M1 activation and recruitment of cultured microglial cells. Cell Physiol Biochem Karger Publishers. 2016;38:859-70.
60. Turtzo LC, Lescher J, Janes L, Dean DD. Macrophagic and microglial responses after focal traumatic brain injury in the female rat. J Neuroinflammation. 2014;11:82-96.
61. Haan N, Zhu B, Wang J, Wei X, Song B. Crosstalk between macrophages and astrocytes affects proliferation, reactive phenotype and inflammatory response, suggesting a role during reactive gliosis following spinal cord injury. J Neuroinflammation. 2015;12:109. BioMed Centra.
62. Barakat R, Redzic Z. Differential cytokine expression by brain microglia/macrophages in primary culture after oxygen glucose deprivation and their protective effects on astrocytes during anoxia. Fluids and Barriers of the CNS. 2015.
63. David S, Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci. 2011;12:388-99.
64. Liu X, Buffington JA, Tjalkens RB. NF-ΚB-dependent production of nitric oxide by astrocytes mediates apoptosis in differentiated PC12 neurons following exposure to manganese and cytokines. Molecular Brain Research. 2005;141:39-47.
65. Giordano G, Pizzurro D, VanDeMark K, Guizzetti M, Costa LG. Manganese inhibits the ability of astrocytes to promote neuronal differentiation. Toxicol Appl Pharmacol. 2009;240:226-35.
66. Aschner M, Erikson KM, Hernández EH, Tjalkens R. Manganese and its role in Parkinson's disease: from transport to neuropathology. Neuromol Med Humana Press Inc. 2009;11:252-66.
67. Welser-Alves JV, Crocker SJ, Milner R. A dual role for microglia in promoting tissue inhibitor of metalloproteinase (TIMP) expression in glial cells in response to neuroinflammatory stimuli. J Neuroinflammation. 2011;8:61.
68. Shih AY. Policing the police: astrocytes modulate microglial activation. Journal of Neuroscience. 2006;26:3887-8.
69. Même W, Calvo C-F, Froger N, Ezan P, Amigou E, Koulakoff A, et al. Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by beta-amyloid. The FASEB Journal Federation of American Societies for Experimental Biology. 2006;20:494-6.
70. Sriram K, Miller DB, O'Callaghan JP. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem. 2006;96:706-18.
71. Conductier G, Blondeau N, Guyon A, Nahon J-L, Rovère C. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. Journal of Neuroimmunology. 2010;224:93-100.
72. Thompson WL, Karpus WJ, Van Eldik LJ. MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult. J Neuroinflammation. 2008;5:35. BioMed Central.
73. Ramesh G, MacLean AG, Philipp MT. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators of Inflammation Hindawi Publishing Corporation. 2013;2013:1-20.
74. Moreno JA, Streifel KM, Sullivan KA, Hanneman WH, Tjalkens RB. Manganese-induced NF-ΚB activation and nitrosative stress is decreased by estrogen in juvenile mice. 2011.
75. Crittenden PL, Filipov NM. Manganese-induced potentiation of in vitro proinflammatory cytokine production by activated microglial cells is associated with persistent activation of p38 MAPK. Toxicology in Vitro. 2008;22:18-27.
76. Kraft ADA, Harry GJG. Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. Int J Environ Res Public Health. 2011;8:2980-3018.